Bonraybio Co., Ltd. (6955.TW) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan

Price
87.30 TWD
Market cap
2.68 bn TWD
P/E (2025)
21.12
P/S (2025)
8.74
Dividend yield
0.00 %
Net margin
33.46 %
Return on equity (ROE)
15.98 %
Return on assets (ROA)
14.24 %

Bonraybio Co., Ltd. financials

Fiscal year20242025
Revenue222.88 m TWD306.31 m TWD
Gross profit174.96 m TWD238.52 m TWD
Operating income60.95 m TWD99.95 m TWD
EBIT68.57 m TWD104.91 m TWD
Net income68.37 m TWD102.51 m TWD
Diluted EPS – continuing operations2.76 TWD4.13 TWD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Bonraybio Co., Ltd.

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.